[go: up one dir, main page]

WO2004071389A3 - Non-steroidal infalmmation inhibitors - Google Patents

Non-steroidal infalmmation inhibitors Download PDF

Info

Publication number
WO2004071389A3
WO2004071389A3 PCT/EP2004/001507 EP2004001507W WO2004071389A3 WO 2004071389 A3 WO2004071389 A3 WO 2004071389A3 EP 2004001507 W EP2004001507 W EP 2004001507W WO 2004071389 A3 WO2004071389 A3 WO 2004071389A3
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
represents hydrogen
nr8cor9
conr8r9
coor7
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2004/001507
Other languages
French (fr)
Other versions
WO2004071389A2 (en
Inventor
Michael David Barker
Derek Anthony Demaine
David House
Graham George Adam Inglis
Michael John Johnston
Haydn Terence Jones
Simon John Fawcett Macdonald
Iain Mcfarlane Mclay
Stephen Shanahan
Philip Alan Skone
Maria Victoria Vinader
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0303523A external-priority patent/GB0303523D0/en
Priority claimed from GB0305721A external-priority patent/GB0305721D0/en
Priority claimed from GB0305717A external-priority patent/GB0305717D0/en
Priority claimed from GB0316865A external-priority patent/GB0316865D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of WO2004071389A2 publication Critical patent/WO2004071389A2/en
Publication of WO2004071389A3 publication Critical patent/WO2004071389A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/02—1,2-Oxazines; Hydrogenated 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A compound of formula (I) wherein: n represents an integer 0, 1 or 2; X represents, O, S, NR6a, or CHR6b; R1 represents hydrogen, halogen such as F, Cl or Br, NO2, hydroxy, cyano, -OC1-6 alkoxy such as methoxy, C1-6 alkyl such as methyl, NR8R9 such as NH2, NR8COR9 such as -NHCHO or -NHCOCH3, COOR7 or CONR8R9; R2 represents hydrogen, halogen such as F, Cl, Br, NO2, hydroxy, cyano, -OC1-6 alkoxy such as methoxy, C1-6 alkyl such as methyl, NR8R9 such as NH2, NR8COR9 such as -NHCHO or -NHCOCH3, COOR7 or CONR8R9; R3 represents hydrogen, halogen such as F, Cl, Br, NO2, hydroxy, cyano, -OC1-6 alkoxy such as methoxy, C1-6 alkyl such as methyl, NR8R9 such as NH2, NR8COR9 such as -NHCHO or -NHCOCH3, COOR7, CONR8R9; R4 represents hydrogen, halogen such as F, Cl, Br, NO2, hydroxy, cyano, -OC1-6 alkoxy such as methoxy, C1-6 alkyl such as methyl, NR8R9 such as NH2, NR8COR9 such as -NHCHO or -NHCOCH3, COOR7 or CONR8R9; R5 represents H, C1-6 alkyl, or C1-6 alkenyl; R6a represents hydrogen, C1-6 alkyl, CO2C1-3 alkyl, COC1-3 alkyl or SO2C1-3 alkyl; R6b represents hydrogen, or C1-6 alkyl; R7 represents hydrogen, C1-6 alkyl, C1-3 alkyleneSiC1-3 alkyl such as -CH2CH2Si(CH3)3; R8 and R9 independently represent hydrogen or C1-6 alkyl; including pharmaceutically acceptable esters, amides and carbamates thereof, salts thereof, solvates thereof, and solvates of such pharmaceutically acceptable esters, amides, carbamates and salts.
PCT/EP2004/001507 2003-02-15 2004-02-13 Non-steroidal infalmmation inhibitors Ceased WO2004071389A2 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB0303523A GB0303523D0 (en) 2003-02-15 2003-02-15 Compounds
GB0303523.5 2003-02-15
GB0305721.3 2003-03-13
GB0305721A GB0305721D0 (en) 2003-03-13 2003-03-13 Compounds
GB0305717A GB0305717D0 (en) 2003-03-13 2003-03-13 Compounds
GB0305717.1 2003-03-13
GB0316865.5 2003-07-18
GB0316865A GB0316865D0 (en) 2003-07-18 2003-07-18 Compounds

Publications (2)

Publication Number Publication Date
WO2004071389A2 WO2004071389A2 (en) 2004-08-26
WO2004071389A3 true WO2004071389A3 (en) 2004-12-02

Family

ID=32872852

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/001507 Ceased WO2004071389A2 (en) 2003-02-15 2004-02-13 Non-steroidal infalmmation inhibitors

Country Status (1)

Country Link
WO (1) WO2004071389A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL373043A1 (en) 2002-03-26 2005-08-08 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
UY28526A1 (en) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma GLUCOCORTICOID MIMETICS, METHODS OF PREPARATION PHARMACEUTICAL COMPOSITIONS AND USES OF THE SAME
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
WO2006000398A1 (en) * 2004-06-28 2006-01-05 Glaxo Group Limited 2,3-benzoxazin derivatives as non-steroidal glucocorticoid receptor modulators
GB0418045D0 (en) 2004-08-12 2004-09-15 Glaxo Group Ltd Compounds
WO2006071609A2 (en) * 2004-12-27 2006-07-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
GB0513297D0 (en) * 2005-06-29 2005-08-03 Glaxo Group Ltd Novel compounds
GB0611587D0 (en) * 2006-06-12 2006-07-19 Glaxo Group Ltd Novel compounds
WO2008000777A2 (en) * 2006-06-29 2008-01-03 Glaxo Group Limited Phenyl- pyrazole derivatives, process for their preparation and their pharmaceutical use
CN101547909A (en) 2006-12-06 2009-09-30 贝林格尔.英格海姆国际有限公司 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2008074814A1 (en) * 2006-12-20 2008-06-26 Glaxo Group Limited Pyrazole derivatives as non-steroidal glucocorticoid receptor ligands
BRPI0915680A2 (en) 2008-06-06 2019-09-24 Boehringer Ingelheim Int glucocorticoid mimetics, methods of preparing them, pharmaceutical compositions, and uses thereof
US9382245B2 (en) 2013-10-11 2016-07-05 Yale University Compounds and methods for treating HIV infections
TWI899455B (en) * 2021-03-23 2025-10-01 美商美國禮來大藥廠 Glucocorticoid receptor agonists

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032584A2 (en) * 1998-11-27 2000-06-08 Schering Aktiengesellschaft Nonsteroidal antiinflammatories
WO2002010143A1 (en) * 2000-07-28 2002-02-07 Schering Aktiengesellschaft Non-steroidal inflammation inhibitors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032584A2 (en) * 1998-11-27 2000-06-08 Schering Aktiengesellschaft Nonsteroidal antiinflammatories
WO2002010143A1 (en) * 2000-07-28 2002-02-07 Schering Aktiengesellschaft Non-steroidal inflammation inhibitors

Also Published As

Publication number Publication date
WO2004071389A2 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
WO2004071389A3 (en) Non-steroidal infalmmation inhibitors
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
EP1760073A4 (en) Sulfonamide compound
WO2004013101A3 (en) N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
NO20062031L (en) Derivatives of N- [phenyl (alkylpeptidn-2-yl) methyl] benzamide, process for its preparation and use in therapeutic media
ES2543607T3 (en) Certain substituted amides, method of obtaining, and method of use
WO2007081571A3 (en) Cetp inhibitors
WO2005074643A3 (en) Benzamide compounds useful as rock inhibitors
HRP20090195T1 (en) MITOTIC CHINESE INHIBITORS
EA200501730A1 (en) DERIVATIVES N-PYRROLIDIN-3-IL-AMIDA AS AN INHIBITORS OF REVERSE CAPTURE OF SEROTONIN AND NORADRENALINE
DK1485377T3 (en) Pyranones are suitable as ATM inhibitors
HRP20090071T3 (en) Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors
PE20011115A1 (en) TRI-ARIL-SUBSTITUTED ETHANS, PDE4 INHIBITORS
NO20071319L (en) Process for the preparation of isothiazole derivatives.
HUP0302930A2 (en) Process for the preparation n-(substituted phenyl)-3-alkyl-,aryl- and heteroaryl-sulfonil-2-hydroxy-2-alkyl- and haloalkylpropanamide compounds
EA200600607A1 (en) IMIDAZOPIRIDIN DERIVATIVES AS AN INDUCED NO SYNTHASE INHIBITORS
HRP20030610B1 (en) Process for the preparation of mesylates of piperazine derivatives
DK1202954T3 (en) Novel aminobenzophenones
ATE374750T1 (en) SEROTONIN RUPUP INHIBITORS
TNSN08161A1 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
EP1798227A4 (en) Serotonin 5-ht3 receptor agonist
NO20061832L (en) Carbamide derivatives of amide type
GB0326964D0 (en) Chemical compounds
GB0403148D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase